BiologicalActivity
Selective,highaffinity5-HT1Areceptorantagonist(Ki=0.6nMinvitro).Enhancestheactionofselective5-HTreuptakeinhibitorsandreversescitalopram-induced(Cat.No.1427)inhibitionofSEROtonergiccellfiring.
LicensingInformation
SoldforresearchpurposesunderagreementfromAstraZeneca
CompoundLibraries
NAD299hydrochlorideisalsoofferedaspartoftheTocriscreenPlus.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
TechnicalData
| M.Wt | 354.85 |
| Formula | C18H23FN2O2.HCl |
| Storage | DesiccateatRT |
| Purity | ≥98%(HPLC) |
| CASNumber | 184674-99-5 |
| PubChemID | 90488823 |
| InChIKey | GSZJANKLCPHEEX-BTQNPOSSSA-N |
| Smiles | FC1=C2C(C[C@@H](N(C4CCC4)C3CCC3)CO2)=C(C(N)=O)C=C1.Cl |
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
SolubilityData
| Solvent | MaxConc.mg/mL | MaxConc.mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 35.48 | 100 | |
| water | 35.48 | 100 |
PreparingStockSolutions
Thefollowingdataisbasedontheproductmolecularweight354.85.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.
| Concentration/SolventVolume/Mass | 1mg | 5mg | 10mg |
|---|---|---|---|
| 1mM | 2.82mL | 14.09mL | 28.18mL |
| 5mM | 0.56mL | 2.82mL | 5.64mL |
| 10mM | 0.28mL | 1.41mL | 2.82mL |
| 50mM | 0.06mL | 0.28mL | 0.56mL |
MolarityCalculator
ReconstitutionCalculator
DilutionCalculator
ProductDatasheets
© 2005- 苏州蚂蚁淘生物科技有限公司 版权所有。
苏ICP备17049038号-11
苏公网安备 32059002001627号
声明：本网站部分产品受外界条件影响（包含但不限于进口国出口国政策限制等因素），无法提供销售服务，下单后，会由客服人员联系厂家确认后另行通知。部分危险品无法清关，请勿下单
我要提问
您的问题将推送给已购用户，TA们将会为你解答。